Arecor Begin Patient Trial Of Revolutionary Insulin For Type 2 Diabetics
The initial administration of Arecor's insulin candidate to a patient marks a significant step forward in the quest to transform the management of type 2 diabetes.
News
Brouhaha screen new film Firebrand
Their new film stars Jude Law, Alicia Vikander and Simon Russell Beale and is directed by Karim Aïnouz
Arctic Shores Revolutionises Recruitment
New Calculus portfolio company Artic Shores helps companies revolutionise recruitment through their innovative technology.
Scancell announces positive response in COVIDITY trial
Scancell continue to make significant strides in its efforts to develop novel immunotherapies for the treatment of cancer and infectious disease.
MIP Discovery secures significant funding
Funding secured from Bill and Melinda Gates Foundation to expand disease testing.
Arecor Announces Transfer Of Novel Therapeutic Product To Hikma
FTSE 250 company Hikma have triggered the transfer of Arecors's AT307 product including a milestone payment.
CEO Q4 2022 Update
Calculus CEO, John Glencross, gives an update on the happenings in Q4 2022.
C4XD signs exclusive global licence worth up to $402 million with AstraZeneca
C4X Discovery continues its progress with the signing of an exclusive global license with AstraZeneca.
Calculus exits Avvio for 5.5x return
Calculus completes exit from Avvio for 5.5x return, a continuation of excellent exits achieved for Calculus investors in the last two years.
Autumn Statement Response
The Government is committed to helping entrepreneurial businesses raise growth capital by continued support of EIS and VCT
XF-73 Dermal infection project advances into clinically enabling safety study as part of ongoing agreement with US Government’s NIAID
Destiny Pharma's potentially revolutionary product 'XF-73' progresses into next stage study.
Open Energy Market has saved the taxpayer over £0.25billion
80% of OEM’s customers won’t have to rely on taxpayer support this winter Saving taxpayers over £250m versus full energy price cap payouts Keeping hundreds of businesses afloat and in control of their costs Open Energy Market (OEM), a leading provider of energy procurement services and net zero technologies, today quantifies the taxpayer savings made …
Calculus Sponsors Spears Awards
Calculus sponsored the HNW wealth manager of the year award.
Arecor announces exclusive specialty hospital formulation collaboration
Arecor continue to make significant strides proving the strength of their technology.
Scancell in-licenses Vaccitech technology advancing Modi-2 towards the clinic
Scancell continue progress for Modi-2 by in-licencing Vaccitech technology.
Arecor’s recent acquisition Tetris Pharma launches key product in Germany
Arecor's subsidiary launch a new treatment option for severe hypoglycaemia for children and adults living with diabetes.
Calculus Bolsters Senior Team With New Investment Director
Elizabeth Klein joins Calculus as a Director within the investment team, bringing a wealth of experience.
Scancell enrols first patient in cancer trial expansion
Scancell said it has enrolled its first patient in the expansion phase of its ModiFY trial.
CEO Q3 2022 Update
Important note: Past performance is not indicative of future performance. Tax benefits depend on the individual circumstances of each investor and may be subject to change in the future. Welcome to our third quarterly update of 2022. This quarter, we are delighted to announce the launch of our HMRC approved Knowledge Intensive EIS Fund, whereby …
Brouhaha’s ‘Lee’ first look and Riff Raff to develop limited series for Netflix
Riff Raff Entertainment update on latest project and Brouhaha release first look of 'Lee'.
Scancell signs exclusive deal with cancer giant Genmab for anti-glycan antibody
Scancell Holdings, Calculus portfolio company, said it has signed a deal worth up to US$208m.
John Glencross Shares Views On Implications Of Inflation Rates
As UK Inflation hits 10.1% John Glencross, CEO of Calculus, Shares his views on the implications.
Wazoku earns B Corp Certification
Wazoku becomes one of the world's first innovation companies to achieve prestigious B-Corp recognition.
Calculus Launches New Knowledge Intensive EIS Fund
Calculus launches new Knowledge Intensive EIS fund, an HMRC approved Fund.